HK1117039A1 - Prevention of hiv-infection with tmc278 - Google Patents

Prevention of hiv-infection with tmc278

Info

Publication number
HK1117039A1
HK1117039A1 HK08107189.8A HK08107189A HK1117039A1 HK 1117039 A1 HK1117039 A1 HK 1117039A1 HK 08107189 A HK08107189 A HK 08107189A HK 1117039 A1 HK1117039 A1 HK 1117039A1
Authority
HK
Hong Kong
Prior art keywords
tmc278
hiv
infection
prevention
Prior art date
Application number
HK08107189.8A
Other languages
English (en)
Inventor
Lieven Elvire Colette Baert
Paulus Joannes Lewi
Jan Heeres
Original Assignee
Janssen R & D Ireland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen R & D Ireland filed Critical Janssen R & D Ireland
Publication of HK1117039A1 publication Critical patent/HK1117039A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK08107189.8A 2005-04-04 2008-06-27 Prevention of hiv-infection with tmc278 HK1117039A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05102616 2005-04-04
PCT/EP2006/061303 WO2006106103A2 (en) 2005-04-04 2006-04-04 Prevention of hiv- infection with tmc278

Publications (1)

Publication Number Publication Date
HK1117039A1 true HK1117039A1 (en) 2009-01-09

Family

ID=34939113

Family Applications (2)

Application Number Title Priority Date Filing Date
HK08107189.8A HK1117039A1 (en) 2005-04-04 2008-06-27 Prevention of hiv-infection with tmc278
HK14112581.4A HK1198936A1 (en) 2005-04-04 2014-12-16 Prevention of hiv-infection by using tmc278 tmc278 hiv

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK14112581.4A HK1198936A1 (en) 2005-04-04 2014-12-16 Prevention of hiv-infection by using tmc278 tmc278 hiv

Country Status (29)

Country Link
US (6) US20080194601A1 (pl)
EP (1) EP1881848B1 (pl)
JP (2) JP5632579B2 (pl)
KR (1) KR101360851B1 (pl)
CN (2) CN101155599A (pl)
AP (1) AP2617A (pl)
AR (1) AR053571A1 (pl)
AU (1) AU2006231585B2 (pl)
BR (1) BRPI0607649B8 (pl)
CA (1) CA2602231C (pl)
CY (1) CY1113950T1 (pl)
DK (1) DK1881848T3 (pl)
EA (1) EA011420B1 (pl)
ES (1) ES2402864T3 (pl)
HK (2) HK1117039A1 (pl)
HR (1) HRP20130296T1 (pl)
IL (1) IL184744A (pl)
ME (1) ME01517B (pl)
MX (1) MX2007012277A (pl)
MY (1) MY150091A (pl)
NZ (1) NZ556659A (pl)
PL (1) PL1881848T3 (pl)
PT (1) PT1881848E (pl)
RS (1) RS52724B (pl)
SI (1) SI1881848T1 (pl)
TW (2) TW201414495A (pl)
UA (1) UA90124C2 (pl)
WO (1) WO2006106103A2 (pl)
ZA (1) ZA200708454B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
TW201414495A (zh) * 2005-04-04 2014-04-16 Tibotec Pharm Ltd Ｈｉｖ-感染之預防
MY150717A (en) * 2006-01-20 2014-02-28 Tibotec Pharm Ltd Long term treatment of hiv-infection with tmc278
AR061620A1 (es) * 2006-06-23 2008-09-10 Tibotec Pharm Ltd Suspensiones acuosas de tmc278
TWI494133B (zh) 2007-03-14 2015-08-01 Tibotec Pharm Ltd 重組用粉末
SG196774A1 (en) * 2008-12-24 2014-02-13 Tibotec Pharm Ltd Implantable devices for treating hiv
SG181759A1 (en) * 2009-12-21 2012-07-30 Janssen R & D Ireland Degradable removable implant for the sustained release of an active compound
DE102011082871A1 (de) * 2011-09-16 2013-03-21 Florian, Prof. Dr. Lang Therapeutische und diagnostische Targets für Autoimmunität, inflammatorische Prozesse und/oder immuner Pathogenese und/oder von Erkrankungen, welche auf Autoimmunität, inflammatorische Prozessen und/oder immuner Pathogenese beruhen
JO3387B1 (ar) 2011-12-16 2019-03-13 Glaxosmithkline Llc مشتقات بيتولين
EA201590862A1 (ru) 2012-12-14 2016-05-31 ГЛАКСОСМИТКЛАЙН ЭлЭлСи Фармацевтические композиции
PE20170691A1 (es) * 2014-09-26 2017-06-13 Glaxosmithkline Intellectual Property (No 2) Ltd Composiciones farmaceuticas de accion prolongada
WO2022079739A1 (en) 2020-10-14 2022-04-21 Cipla Limited Fixed dose compositions of cabotegravir and rilpivirine

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06316524A (ja) 1992-09-11 1994-11-15 Naoyuki Inoue 抗エイズウイルス剤
US6258932B1 (en) 1999-08-09 2001-07-10 Tripep Ab Peptides that block viral infectivity and methods of use thereof
RU2239435C2 (ru) 2000-03-30 2004-11-10 Бристол-Маерс Сквибб Компани Гранулы пролонгированного высвобождения, содержащие ставудин
US20040115268A1 (en) * 2000-04-26 2004-06-17 Control Delivery Systems, Inc. Systemic delivery of antiviral agents
MY169670A (en) * 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
US20050287177A1 (en) 2002-11-08 2005-12-29 Glaxo Group Unlimited And Smithkline Beecham Corp. Pharmaceutical compositions
ES2477118T3 (es) 2002-11-18 2014-07-15 Polaris Group Método para inhibir la replicaci�n viral in vivo
CL2004000192A1 (es) 2003-02-07 2005-03-18 Janssen Pharmaceutica Nv Uso de compuestos derivados de 2-aminopirimidina para preparar un medicamento para la prevencion de una infeccion por vih relaciones sexuales o un contacto intimo en la pareja.
JP2006518373A (ja) 2003-02-21 2006-08-10 トリペップ アクチ ボラゲット Ｈｉｖ複製を抑制するためのグリシンアミド誘導体
TW201414495A (zh) * 2005-04-04 2014-04-16 Tibotec Pharm Ltd Ｈｉｖ-感染之預防
MY150717A (en) * 2006-01-20 2014-02-28 Tibotec Pharm Ltd Long term treatment of hiv-infection with tmc278
AR061620A1 (es) * 2006-06-23 2008-09-10 Tibotec Pharm Ltd Suspensiones acuosas de tmc278

Also Published As

Publication number Publication date
US10765674B2 (en) 2020-09-08
AP2617A (en) 2013-03-18
HRP20130296T1 (hr) 2013-04-30
EA200702169A1 (ru) 2008-02-28
KR101360851B1 (ko) 2014-02-11
TWI457136B (zh) 2014-10-21
PL1881848T3 (pl) 2013-06-28
EA011420B1 (ru) 2009-02-27
CY1113950T1 (el) 2016-07-27
US20160151276A1 (en) 2016-06-02
CN103860560A (zh) 2014-06-18
US20110077261A1 (en) 2011-03-31
BRPI0607649B1 (pt) 2019-08-06
NZ556659A (en) 2012-03-30
ZA200708454B (en) 2009-03-25
SI1881848T1 (sl) 2013-05-31
JP2013079275A (ja) 2013-05-02
IL184744A0 (en) 2007-12-03
US20220071997A1 (en) 2022-03-10
JP2008534651A (ja) 2008-08-28
DK1881848T3 (da) 2013-04-15
BRPI0607649B8 (pt) 2021-05-25
TW200709818A (en) 2007-03-16
CA2602231C (en) 2014-03-25
HK1198936A1 (en) 2015-06-19
RS52724B (en) 2013-08-30
UA90124C2 (ru) 2010-04-12
JP5632579B2 (ja) 2014-11-26
TW201414495A (zh) 2014-04-16
BRPI0607649A2 (pt) 2009-09-22
MX2007012277A (es) 2007-10-17
US20160296519A1 (en) 2016-10-13
US20080194601A1 (en) 2008-08-14
AP2007004178A0 (en) 2007-10-31
ME01517B (me) 2014-04-20
US20200397783A1 (en) 2020-12-24
MY150091A (en) 2013-11-29
WO2006106103A2 (en) 2006-10-12
AU2006231585A1 (en) 2006-10-12
ES2402864T3 (es) 2013-05-09
WO2006106103A3 (en) 2007-06-07
PT1881848E (pt) 2013-04-15
KR20080009051A (ko) 2008-01-24
EP1881848B1 (en) 2013-01-16
CA2602231A1 (en) 2006-10-12
AR053571A1 (es) 2007-05-09
CN101155599A (zh) 2008-04-02
EP1881848A2 (en) 2008-01-30
AU2006231585B2 (en) 2012-02-02
IL184744A (en) 2015-05-31

Similar Documents

Publication Publication Date Title
ZA200708454B (en) Prevention of HIV-infection with TMC278
AP2936A (en) Long term treatment of HIV-infection with TMC278
GB0512940D0 (en) Compounds and their use
GB0520743D0 (en) Compounds and their use
EP1912921A4 (en) COMPOUNDS ON TETRAAZAPORPHYRINBASE AND ITS USES
HK1161122A1 (en) Use of 24-norudca 24-norudca
EP1921066A4 (en) PYRIDYLPHENOL COMPOUND AND USE THEREOF
IL185223A0 (en) Compounds and uses thereof
EP1931370A4 (en) USE OF DES-ASPARTATE-ANGIOTENSIN I
GB0520737D0 (en) The preparation of olive oil
GB0804899D0 (en) Compound composition and use
GB0608797D0 (en) Novel agents and the use thereof
ZA200804378B (en) Iminopropene compound and use thereof
AU3686P (en) DOW30 Acmena smithii
GB0515688D0 (en) Compounds and their uses
GB0510067D0 (en) Compounds and their uses
GB0522867D0 (en) Compounds and their uses
GB0506545D0 (en) Compounds and their uses
GB0514471D0 (en) Compounds and their uses
GB0510263D0 (en) Compounds and their uses
GB0515913D0 (en) Compounds and their uses
GB0525328D0 (en) Compounds and their uses
GB0521176D0 (en) The easy light and fitting
ZA200705410B (en) Prodrugs of 2,4-pyrimidinediamine compounds and their uses
GB0521272D0 (en) Compounds and uses thereof